Cardiac dysfunction and prolonged hemodynamic deterioration after implantable cardioverter-defibrillator shock in patients with systolic heart failure

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 5, 2012, Pages 898-905

  Toh, Norihisa ^a   Nishii, Nobuhiro ^a   Nakamura, Kazufumi ^a   Tada, Takeshi ^a   Oe, Hiroki ^a,b   Nagase, Satoshi ^a   Kohno, Kunihisa ^a   Morita, Hiroshi ^a   Kusano, Kengo F ^a   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cardiac function; Echocardiography; Hemodynamics; Implanted cardioverter defibrillators; Ventricular fibrillation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEFIBRILLATION; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE RELAXATION; HEART VENTRICLE FUNCTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECKLE TRACKING ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; ANALYSIS OF VARIANCE; BLOOD; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, SYSTOLIC; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOGLOBIN; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STROKE VOLUME; TROPONIN I; TROPONIN T; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84872025935     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.970285     Document Type: Article

References (29)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
3. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011;57:556-562.
4. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122:2359-2367.
5. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017.
6. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760-3765.
7. Michowitz Y, Lellouche N, Contractor T, Bourke T, Wiener I, Buch E, Boyle N, Bersohn M, Shivkumar K. Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace. 2011;13:683-688.
8. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, Krahn A, Parkash R, Khaykin Y, Philippon F, Guerra P, Kimber S, Cameron D, Healey JS. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm. 2008;5:387-390.
9. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol. 2007;30:675-700.
10. Kerber RE, Martins JB, Gascho JA, Marcus ML, Grayzel J. Effect of direct-current countershocks on regional myocardial contractility and perfusion. Experimental studies. Circulation. 1981;63:323-332.
11. Ditchey RV, LeWinter MM. Effects of direct-current electrical shocks on systolic and diastolic left ventricular function in dogs. Am Heart J. 1983;105:727-731.
12. Yasuda S, Shishido T, Goto Y. Severe diastolic dysfunction with preserved energy conversion efficiency after countershock. Am J Physiol. 1997;273(2 Pt 2):H583-H592.
13. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol. 2006;47:1313-1327.
14. Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation. 2007;115:1376-1383.
15. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA; Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738-3744.
16. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456-2467.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
18. Runsiö M, Bergfeldt L, Brodin LA, Ribeiro A, Samuelsson S, Rosenqvist M. Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography. Eur Heart J. 1997;18:124-131.
19. Stoddard MF, Redd RR, Buckingham TA, McBride LR, Labovitz AJ. Effects of electrophysiologic testing of the automatic implantable cardioverter- defibrillator on left ventricular systolic function and diastolic filling. Am Heart J. 1991;122(3 Pt 1):714-719.
20. Skhirtladze K, Mora B, Moritz A, Birkenberg B, Ankersmit HJ, Dworschak M. Impaired recovery of cardiac output and mean arterial pressure after successful defibrillation in patients with low left ventricular ejection fraction. Resuscitation. 2010;81:1123-1127.
21. Steinbeck G, Dorwarth U, Mattke S, Hoffmann E, Markewitz A, Kaulbach H, Tassani P. Hemodynamic deterioration during ICD implant: predictors of high-risk patients. Am Heart J. 1994;127(4 Pt 2):1064-1067.
22. Jones DL, Narayanan N. Defibrillation depresses heart sarcoplasmic reticulum calcium pump: a mechanism of postshock dysfunction. Am J Physiol. 1998;274(1 Pt 2):H98-105.
23. Fast VG, Cheek ER, Pollard AE, Ideker RE. Effects of electrical shocks on Cai2+ and Vm in myocyte cultures. Circ Res. 2004;94:1589-1597.
24. Ristagno G, Wang T, Tang W, Sun S, Castillo C, Weil MH. High-energy defibrillation impairs myocyte contractility and intracellular calcium dynamics. Crit Care Med. 2008;36(11 Suppl):S422-S427.
25. Yano M, Ikeda Y, Matsuzaki M. Altered intracellular Ca2+ handling in heart failure. J Clin Invest. 2005;115:556-564.
26. Kitakaze M, Weisman HF, Marban E. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation. 1988;77:685-695.
27. Piacentino V 3rd, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM, Houser SR. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res. 2003;92:651-658.
28. Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res. 1991;68:1713-1721.
29. Tokano T, Bach D, Chang J, Davis J, Souza JJ, Zivin A, Knight BP, Goyal R, Man KC, Morady F, Strickberger SA. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol. 1998;9:791-797.